Clinical Trial Update: Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing outpatient discharge therapy with saxagliptin/metformin XR versus glipizide XL for type 2 diabetes with severe hyperglycemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• glipizide XL (glipizide XL)
• saxagliptin/metformin XR (saxagliptin/metformin XR)

Snippet

Sponsor: Cook County Health | Conditions: Diabetes Mellitus Type 2, Hyperglycemia | Phase 4 | Status: COMPLETED